World ADC London brings together the latest ADC science, clinical data and lessons learned to enable drug developers to maximise the clinical therapeutic window of your ADC.
World ADC London remains Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
Some of the highlights from this year’s meeting include, validating novel ADC targets, improving understanding of mechanisms driving toxicity in clinical development and robustly scaling up process development to support commercialisation.
320 experts across 140+ active organisations united at this industry focussed conference and fostered new connections, developed business relationships and met with current partners.
Register your interest to join us in 2020 at Europe’s longest standing and most comprehensive ADC conference to power the development of your ADC pipeline.
“World ADC conferences from Hanson Wade are a key part of the ADC ecosystem, contributing to the growth of knowledge, ideas, and community network.”
"A great place to meet peers and partners, learn about novel ADC approaches and better understand the direction, the field is headed for."
“Excellent talks by all the speakers with a transparent and frank attitude to share good and bad experiences gained in the challenging world of ADCs in oncology. A deep and valuable analysis of the state of the art of ADCs with a focus on solid tumors potential.”
- Menarini Ricerche